Aurobindo Pharma,
and
are among five companies in the race to acquire bankrupt Sterling Biotech through the liquidation process. The other two are integrated pharmaceutical manufacturing solutions company ACG Associated Capsules and Gland Celsus Bio Chemicals.
The liquidator had invited bids on July 21 for the worlds sixth-largest manufacturer of pharmaceutical gelatin to sell the company as a going concern at a reserve price of Rs 548.46 crore. Lovkesh Batra, a member of the Mamta Binani-led liquidation team, confirmed the development but declined to provide details. The shortlist was whittled down from about a dozen aspirants, he said.
The five bidders didnt respond to queries.
The qualified bidders will have a time of 15 days beginnin…
Read the full article at: https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-cadila-upl-in-fray-to-acquire-bankrupt-sterling-biotech/articleshow/85526467.cms
